Major Health System Drops Cerner EHR, Signs on with Epic Systems

Christopher Jason | February 12, 2020

Major Health System Drops Cerner EHR, Signs on with Epic Systems
AdventHealth, a Florida-based health system and one of the nation’s largest faith-based health systems, has announced it will transition away from Cerner and will implement Epic Systems EHR across its 50 hospital campuses and 1,200-plus care sites that ranges over nine states.The health system did not comment whether the full Epic transition was due to its issues with the Cerner revenue cycle management platform, although the tool does have a history of underperforming for health systems.The Epic implementation will allow the health system to be on a single, integrated platform. This platform will include its EHR and a revenue cycle management system that covers its acute care, physician practice, ambulatory, urgent care, home health, and hospice facilities. The transition to Epic will begin in March and it is expected to be completed in roughly three years, explained the health system.

Spotlight

Pancreatic cancer is caused by abnormal growth of the cells in the pancreas, a glandular organ behind the stomach. It is estimated that pancreatic cancer will affect one in 67 people in the U.S. in 2015. Due to the location, it is sometimes hard to diagnose in the early stages, making this one of th


Other News

HEALTH TECHNOLOGY

PulsePoint Releases Next Generation Health Media Platform With Advanced Automation And AI

PulsePoint | July 06, 2021

PulsePoint, a technology company revolutionizing health decision-making in real-time, today announced the next generation launch of its digital media buying platform, Life by PulsePoint™. Its enhanced AI and automation simplifies and supercharges the media planning, activation, and optimization processes. Designed for the self-serve programmatic trader, these updates promote efficiencies and surface predictive and in-flight campaign analytics for quick strategic decisioning to yield higher media return on investment. Built upon PulsePoint's extensive data foundation, Genome™, that proactively uses microdata to capture attention when intent is signal...

Read More

HEALTH TECHNOLOGY

Future Health announced today that it has completely digitalised its annual in-person event at ExCeL London

Future Health | March 02, 2021

Future Health has completely rebranded during lockdown, and the flagship face-to-face event Future Health Innovations at ExCeL is now complemented by a global virtual conference series, under the brand UK Health Week. Free for delegates to attend, it is CPD and CME accredited. Participants will be able to connect, meet buyers and partake in cross border purchasing, education and deal making, enabling an increased ROI and profitable encounters with its AI powered networking software. Further Health Weeks are being rolled out around the world over the course of the coming months, and will be territory specific. Dawn Barclay-Ross, Event Director commented: “I think ...

Read More

HEALTH TECHNOLOGY

L2Mtech GmbH Receives CE Mark Approval on 6(SIX) products for Cardiovascular and Endovascular Applications

L2Mtech | February 17, 2021

CE Mark Approval for LimusTrack™, Sirolimus Eluting Coronary Stent System for Cardiovascular Applications. CE Mark Approval for LomiFlow™, Paclitaxel Drug Eluting Balloon for Cardiovascular Applications CE Mark Approval for PearlFlow™, Paclitaxel Drug Elutin Balloon for Endovascular Applications CE Mark Approval for PearlFlow NS™, Self Expandable Nitinol Stent System for Endovascular Applications CE Mark Approval for FlexiTrack 018™, Peripheral Balloon Catheter for Endovascular Applications CE Mark Approval for

Read More

CMS to pay providers via MIPS for participating in COVID-19 drug treatment trials

CMS | April 21, 2020

Clinicians can earn a credit via the Merit-based Incentive Payment System (MIPS) if they participate in a clinical trial and report clinical information on COVID-19, the Trump administration announced late Monday. The Centers for Medicare & Medicaid Services (CMS) said Monday that the goal of the new credit is to provide data that will be vital to making treatments to combat the virus. “The best scientific and medical minds in the world are working night and day to find treatments to combat coronavirus,” CMS Administrator Seema Verma said in a statement Monday. “But without solid data, their efforts are liable to run against a brick wall.”...

Read More

Spotlight

Pancreatic cancer is caused by abnormal growth of the cells in the pancreas, a glandular organ behind the stomach. It is estimated that pancreatic cancer will affect one in 67 people in the U.S. in 2015. Due to the location, it is sometimes hard to diagnose in the early stages, making this one of th

Resources

Events